Fol. Biol. 2008, 54, 134-140
https://doi.org/10.14712/fb2008054040134
Determination of Angiogenic Factors in Serum by Protein Array in Patients with Renal Cell Carcinoma
References
1. 2002) Serum angiogenic activity: diagnostic relevance in renal cell carcinoma. Eur. Urol. 42, 364-369.
< , W. D., Bentas, W., Glienke, W., Linneweber, J., Jonas, D., Binder, J., Kramer, W., (https://doi.org/10.1016/S0302-2838(02)00359-7>
2. 2001) Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: allergics vs. non-allergics. J. Immunol. Methods. 254, 109–118.
< , E. B., Stahl, J. L., Lowe, L., Chen, R., Morgan, E., Wilson, J., Varro, R., Chan, A., Graziano, F. M., Barney, N. P. (https://doi.org/10.1016/S0022-1759(01)00407-0>
3. 2004) Direct comparison of traditional ELISAs and membrane protein arrays for detection and quantification of human cytokines. J. Immunol. Methods 284, 99-106.
< , S., Siddiquiq, J., Remick, D. (https://doi.org/10.1016/j.jim.2003.10.011>
4. 2002) Inflammation and cancer. Nature 420, 860-867.
< , L. M., Werb, Z. (https://doi.org/10.1038/nature01322>
5. 2002) Mesenchymal-epithelial interactions in lung development and repair: are modeling and remodeling the same process? Am. J. Physiol. Lung Cell Mol. Physiol. 283, L510–L517.
< , F., Minoo, P., Plopper, C. G., Schuger, L., Shannon, J., Torday. J. S. (https://doi.org/10.1152/ajplung.00144.2002>
6. 2003) Angiogenic and angiostatic factor in the molecular control of angiogenesis. Q. J. Nucl. Med. 47, 149-161.
, J. H., Hirth, A., Kurowska-Stolarska, M., Gay, R. E., Gay, S., Distler, O. (
7. 2001) Angiogenic factors: vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (b-FGF) are not necessarily elevated in patients with advanced renal cell carcinoma. Anticancer Res. 21, 1423-1429.
, M., Lennermas, B., Larson, A., Kälkner, K. M. (
8. 1998) Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients. J. Clin. Oncol. 16, 3129-3136.
< , U., Kueng, W., Schlaeppi, J. M., Roesel, J. L., Benz, C., Mueller, H., Matter, A., Zuber, M., Luescher, K., Litschgi, M., Schmitt, M., Foekens J. A., Eppenberger-Castori, S. (https://doi.org/10.1200/JCO.1998.16.9.3129>
9. 1998) Development of mini-gel technology in two-dimensional electrophoresis for mass-screening of samples: application to tears. Electrophoresis 9, 852-855.
< , M. J., Molloy, M. P, Walsh, B. J., Willcox, M. D., Morfia, C. A., Williams, K. L. (https://doi.org/10.1002/elps.1150190541>
10. Greene, F. L., Page, D., Morow, M., et al. (2002) AJCC Cancer Staging Manual. 6th ed. Springer, New York.
11. 1979) Platelet-derived growth factor: purification and partial characterization. Proc. Natl. Acad. Sci. USA 76, 3722-3726.
< , C. H., Westermark, B., Wasteson, A. (https://doi.org/10.1073/pnas.76.8.3722>
12. 2001) Quantification and in situ localization of MCP-1 mRNA and its relation to the immune response of renal cell carcinoma. Cytokine 13, 227-233.
< , B., Johanns, U., Kugler, A., Reffelmann M., Radzun, H. J. (https://doi.org/10.1006/cyto.2000.0823>
13. 2001) Two-dimensional analysis of tear protein patterns of diabetic patients. Electrophoresis 22, 1838-1844.
< , S., Grus, F. H., Sabuncuo, P., Augustin, A. J. (https://doi.org/10.1002/1522-2683(200105)22:9<1838::AID-ELPS1838>3.0.CO;2-7>
14. 2001) Simultaneous detection of multiple cytokines from conditioned media and patient’s sera by an antibody-based protein array system. Anal. Biochem. 294, 55-62.
< , R. P., Huang, R., Fan, Y., Lin, Y. (https://doi.org/10.1006/abio.2001.5156>
15. 1997) A putative angiogenin receptor in angiogenin-responsive human endothelial cells. Proc. Natl. Acad. Sci. USA 94, 2204-2209.
< , G. F., Riordan, J. F., Vallee, B. L. (https://doi.org/10.1073/pnas.94.6.2204>
16. 2005) The inflammatory cytokine tumor necrosis factor-α regulates chemokine receptor expression on ovarian cancer cells. Cancer Res. 65, 10355-10362.
< , H., Hagemann, T., Szlosarek, P. W., Balkwill, F. R., Wilson J. R. (https://doi.org/10.1158/0008-5472.CAN-05-0957>
17. 2006) Distinct role of macrophages in different tumor microenvironments. Cancer Res. 66, 605-612.
< , C. E., Pollard, J. W. (https://doi.org/10.1158/0008-5472.CAN-05-4005>
18. 2007) The role of PDGF in radiation oncology. Radiat. Oncol. 2, 5.
< , M., Jendrossek, V., Belka, C. (https://doi.org/10.1186/1748-717X-2-5>
19. 1997) Alveolar macrophages stimulated with titanium dioxide, chrysotile asbestos, and residual oil fly ash upregulate the PDGF receptor-α on lung fibroblasts through an IL-1β-dependent mechanism. Am. J. Respir. Cell Mol. Biol. 16, 283-292.
< , P. M., Coin, P. G., Badgett, A., Morgan, D. L., Bonner, J. C. (https://doi.org/10.1165/ajrcmb.16.3.9070613>
20. 1998) Hypoxia down-regulates MCP-1 expression: implications for macrophage distribution in tumors. J. Leukoc. Biol. 63, 758-765.
< , R. P. M., Turner, L., Burke, F., Balkwill, F. R. (https://doi.org/10.1002/jlb.63.6.758>
21. 1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315-328.
< , M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H., Folkman, J. (https://doi.org/10.1016/0092-8674(94)90200-3>
22. 2001) Involvement of plateled-derived growth factor in disease: development of specific antagonists. Adv. Cancer Res. 80, 1-38.
< , A., Heldin, C. H. (https://doi.org/10.1016/S0065-230X(01)80010-5>
23. 2005) Circulating levels of angiogenic cytokines can predict tumour progression and prognosis in neuroendocrine carcinomas. Clin. Endocrinol. 62, 434-443.
< , M. E., Hassler, G., Baum, U., Hahn, E. G., Lohmann, T., Schuppan, D. (https://doi.org/10.1111/j.1365-2265.2005.02238.x>
24. 2005) Membrane array characterization of 80 chemokines, cytokines, and growth factors in open- and closed-eye tears: angiogenin and other defense system constituents. Invest. Ophthalmol. Vis. Sci. 46, 1228-1238.
< , R. A., Conradi, L., Krumholz, D., Beaton, A., Sathe, S., Morris, C. (https://doi.org/10.1167/iovs.04-0760>
25. 2000) Serum level of angiogenin in breast cancer. Anticancer Res. 20, 4769-4771.
, S. M., Eng, H. L., Chen, W. J., Chou F. F., Chen, H. S. (
26. 2006) Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur. J. Cancer 42, 717-727.
< , A., Schioppa, T., Mantovani, A., Allavena, P. (https://doi.org/10.1016/j.ejca.2006.01.003>
27. 2004) Inflammatory response after abdominal surgery. Best Pract. Res. Clin. Anaesthesiol. 18, 439-459.
< , B., Teklote, J. R., Hartel, M., Friess, H., Büchler, M. W. (https://doi.org/10.1016/j.bpa.2003.12.006>
28. 2005) Targeted agents for the treatment of advanced renal cell carcinoma. Cancer 104, 2323-2333.
< , W. M. (https://doi.org/10.1002/cncr.21453>
29. 2003) Expression of plateled-derived growth factor-α α receptor is associated with tumor progression in clear cell renal cell carcinoma. Am. J. Clin. Pathol. 120, 107-112.
< , I., Birner, P., Träxler, M., Marberger, M., Haitel, A. (https://doi.org/10.1309/LQ9EMK8QKE75NGGX>
30. 2007) Prognostic significance of CD44, plateled-derived growth factor receptor α, and cyclooxygenase 2 expression in renal cell carcinoma. Arch. Pathol. Lab. Med. 131, 261-267.
< , O. W., Kramer, B., Shideler, B., Danley, M., Kimler, B. F., Holzbeierlein, J. (https://doi.org/10.5858/2007-131-261-PSOCPG>
31. 2000) Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human brest cancer. Clin. Cancer Res. 6, 3282-3289.
, T., Toi, M., Saji, H., Muta, M., Bando, H., Kuroi, K., Koike, M., Inadera, H., Matsushima, K. (
32. 1999) Renal cell carcinoma: relevance of angiogenetic factors. Anticancer Res. 19, 1537-1540.
, H. W., Bichler, K. H., Feil, G., Loeser, W., Lahme, S., Petri, E. (
33. 2000) Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: Prolonged persistence of neutrophils and macrophages during the late phase of repair. J. Invest. Dermatol. 115, 245-253.
< , C., Kämpfer, H., Stallmeyer, B., Pfeilschifter, J., Frank, S. (https://doi.org/10.1046/j.1523-1747.2000.00029.x>
34. 2006) Blocking plateled-derived growth factor-D/plateled-derived growth factor receptor β signaling inhibits human renal cell carcinoma progression in an orthotopic mouse model. Cancer Res. 65, 5711-5719.
< , L., Tong, R., Cochran, D. M., Jain, R. K. (https://doi.org/10.1158/0008-5472.CAN-04-4313>